General Surgery Devices are used in diagnostic and surgical interventions primarily for the gastrointestinal tract, abdomen, and pelvis. Endoscopic Retrograde Cholangiopancreatography (ERCP) is a combined endoscopic and radiologic intervention for the ducts draining the liver and pancreas which includes bile ducts, gallbladder, and pancreatic ducts. GlobalData uses proprietary data and analytics to provide a comprehensive report on the ercp and ptc devices devices market, including market shares of different players within Italy. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the ercp and ptc devices market in Italy was Boston Scientific followed by Cook Medical, Olympus, Merit Medical Systems and ConMed.
Percutaneous Transhepatic Cholangiography (PTC) is useful in accessing the biliary tree when a high-grade stricture precludes endoscopic visualization or when prior surgery makes endoscopic access difficult. ERCP and PTC devices include ERCP & PTC Cannula/Catheters, Dilators, ERCP & PTC Guidewires, Sphincterotomes and Stone Extractors.
The value of the ercp and ptc devices devices market within Italy was expected to be over $20m in 2023.
For the latest complete market share analysis of ercp and ptc devices device market in Italy, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
